Somatostatin receptor subtype 4 (SSTR4) agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9789082
SERIAL NO

15157624

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTREXION THERAPEUTICS CORPORATION509 SOUTH EXETER STREET BALTIMORE MD 21202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cui, Yunhai Biberach an der Riss, DE 11 34
Doods, Henri Warthausen, DE 113 1347
Ferrara, Marco San Donato, IT 59 498
Giovannini, Riccardo Verona, IT 83 626
Just, Stefan Biberach an der Riss, DE 8 16
Kuelzer, Raimund Mittelbiberach, DE 31 312
Lingard, Iain Monza, IT 24 65
Mazzaferro, Rocco San Giuliano, IT 22 146
Rudolf, Klaus Warthausen, DE 136 1766

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00